
|Articles|May 1, 2003
Risky Reactions
Author(s)Lisette Hilton
Bal Harbour, Fla. - Serious drug eruptions are rare; however, in their daily practice dermatologists are often confronted with symptoms, such as rashes, and might be confused about whether the causes are infection- or drug-related, Ronald C. Hansen, M.D., said at the annual Masters of Pediatrics Conference, hosted by the University of Miami School of Medicine.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
Dermatology Conferences and Meetings Calendar: December 2025
4
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
5


















